Citrus compound shows promise for fatty liver in early studies

Early research suggests nobiletin, a compound in orange peel, may improve metabolic markers in fatty liver disease.

Citrus compound shows promise for fatty liver in early studies

Image: news-medical.net

Early-stage scientific research indicates that nobiletin, a bioactive compound found in the peel of oranges and other citrus fruits, may have beneficial effects on metabolic health, including non-alcoholic fatty liver disease (NAFLD). A 2020 study published in the Journal of Lipid Research by researchers at the University of Western Ontario found that nobiletin reduced liver fat and reversed atherosclerosis in mouse models of metabolic syndrome.

The compound appears to work by improving the body's sensitivity to insulin and enhancing the metabolism of fats. However, experts emphasize that these findings are from preclinical animal studies. The concentration of nobiletin in the edible fruit flesh is much lower than in the peel used in research extracts.

Human clinical trials are necessary to confirm these effects and determine safe, effective dosages. Medical professionals advise that no single food is a cure for NAFLD, which is managed through overall diet, weight loss, and exercise. Consuming whole oranges provides fiber and vitamin C but should be part of a balanced dietary pattern.

ā“ Frequently Asked Questions

What is nobiletin?

Nobiletin is a flavonoid antioxidant compound found primarily in the peel of citrus fruits like oranges and tangerines.

Can eating oranges cure fatty liver disease?

No. While early research on a specific compound is promising, no single food can cure NAFLD, which requires comprehensive lifestyle management.

Have there been human trials on nobiletin for liver health?

As of April 2026, human clinical trials specifically for NAFLD are limited; most evidence comes from laboratory and animal studies.

šŸ“° Sources:
news-medical.net → news.google.com →
Share: